What is it used for?
GOMEKLI is indicated for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection .GOMEKLI is indicated for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection .
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- mirdametinibmirdametinib
- Form and strength
- CAPSULE · 1 mg; CAPSULE · 2 mg; TABLET, FOR SUSPENSION · 1 mgCAPSULE · 1 mg; CAPSULE · 2 mg; TABLET, FOR SUSPENSION · 1 mg
- Manufacturer / applicant
- SPRINGWORKS THERAPEUTICS, INC.SPRINGWORKS THERAPEUTICS, INC.
Capsules: 1 mg: light green body and cap with “MIR 1 mg” printed on the cap in white ink. 2 mg: white body and a blue-green cap with “MIR 2 mg” printed on the cap in white ink. …Capsules: 1 mg: light green body and cap with “MIR 1 mg” printed on the cap in white ink. 2 mg: white body and a blue-green cap with “MIR 2 mg” printed on the cap in white ink. …
Safety and clinical review
- Ocular ToxicityOcular Toxicity
- Left Ventricular DysfunctionLeft Ventricular Dysfunction
- Dermatologic Adverse ReactionsDermatologic Adverse Reactions
- Embryo-Fetal ToxicityEmbryo-Fetal Toxicity
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is GOMEKLI used for?
GOMEKLI is indicated for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection .GOMEKLI is indicated for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection .
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of GOMEKLI should I ask about?
CAPSULE · 1 mg; CAPSULE · 2 mg; TABLET, FOR SUSPENSION · 1 mgCAPSULE · 1 mg; CAPSULE · 2 mg; TABLET, FOR SUSPENSION · 1 mg
Read the primary sourceWhat determines the price of GOMEKLI?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using GOMEKLI?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.